DSO National Laboratories and A*STAR's Diagnostics Development (DxD) Hub in Singapore have jointly developed RESOLUTE 2....
A unique Beta 1,3-1,6 Glucan produced by the AFO-202 strain of a black yeast Aureobasidium pullulans is worth considerin...
Taiwan based Heroic-Faith which uses deep learning and other forms of AI to develop algorithms that assist in the identi...
Singapore researchers have developed a unique and rapid SARS-CoV-2 surrogate virus neutralisation test (sVNT) to determi...
Singapore's Clinician innovators from SingHealth hospitals viz., KK Women’s and Children’s Hospital (KKH), S...
The Israel Ministries of Defense, Foreign Affairs and Health will lead a unique operation with their Indi...
MP Biomedicals Asia Pacific Pte Ltd in collaboration with Singapore's A*STAR has developed ASSURE®&nb...
Ashwini Kumar Choubey, Minister of State for Health and Family Welfare, Government of India received the first tranche o...
The two leading vaccine candidates CanSinoBIO of China and AZD1222 of UK have proven the safety and efficacy a...
PerkinElmer, Inc., a global leader committed to innovating for a healthier world, on 21 July 2020 announced th...
PerkinElmer, Inc., a global leader committed to innovating for a healthier world, has announced that it has launched two...
Taiwan's Bluesense Diagnostics, ViroTrack Sero COVID-19 IgA+IgM/IgG Ab is an in vitro immuno-magnetic (IMA) as...
IQVIA™, on 14 July 2020 announced its collaboration with AstraZeneca to accelerate the development of a potential ...
Interim results from the ongoing Phase I/II COV001 trial, led by Oxford University, showed AZD1222 was tolerated and gen...
Pfizer Inc. and BioNTech SE have announced the execution of an agreement with the U.S. Department of Health and Human Se...
The Therapeutic Goods Administration (TGA), Division of the Australian Department of Health, has granted pr...
South Korea based Celltrion Group has announced the launch of its Phase I human clinical trial investigating a potential...
US based Arcturus Therapeutics Holdings Inc., a leading clinical-stage messenger RNA medicines company focused on the di...
